Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference28 articles.
1. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty: the EPIC Investigation;N Engl J Med,1994
2. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization;N Engl J Med,1997
3. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study;Lancet,1997
4. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II;Lancet,1997
5. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty: randomised efficacy study of Tirofiban for outcomes and restenosis;Circulation,1997
Cited by 537 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antithrombotic Therapy in Acute Coronary Syndrome;Interventional Cardiology Clinics;2024-10
2. A dual-center analysis of conservative versus liberal glycoprotein IIb–IIIa antagonist strategies in the treatment of ST-elevation myocardial infarction;Scientific Reports;2024-07-01
3. Conservative vs. Liberal Glycoprotein IIb-IIIa Antagonist Strategies in the Treatment of ST-Elevation Myocardial Infarction: A Dual-Center Analysis;2024-01-10
4. Optimal Antithrombotic Strategies in Cardiogenic Shock;Journal of Clinical Medicine;2024-01-03
5. GPIIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction - Less Is More?;Cardiovascular Revascularization Medicine;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3